Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
3.12M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
-1.31M
-
Total reported value, excl. options
-
$12.8M
-
Value change
-
-$495K
-
Number of buys
-
13
-
Number of sells
-
-17
-
Price
-
$0.35
Significant Holders of Passage BIO, Inc. - COMMON STOCK (PASG) as of Q1 2025
47 filings reported holding PASG - Passage BIO, Inc. - COMMON STOCK as of Q1 2025.
Passage BIO, Inc. - COMMON STOCK (PASG) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
.
Largest 10 shareholders include Lynx1 Capital Management LP (9.26M shares), ORBIMED ADVISORS LLC (7.03M shares), Vestal Point Capital, LP (6.1M shares), New Leaf Venture Partners, L.L.C. (2.5M shares), Erste Asset Management GmbH (2.46M shares), VANGUARD GROUP INC (2.07M shares), TANG CAPITAL MANAGEMENT LLC (1.5M shares), RENAISSANCE TECHNOLOGIES LLC (1.41M shares), ACADIAN ASSET MANAGEMENT LLC (934K shares), and BlackRock, Inc. (718K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.